INTERNATIONAL BIOTECHNOLOGY TRUST PLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 221 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$593,520
-12.7%
24,0000.0%0.20%
-3.4%
Q2 2023$679,680
-96.8%
24,000
+4942.0%
0.21%
-7.6%
Q2 2022$21,500,000
+2941.0%
476
-97.8%
0.22%
+40.9%
Q1 2022$707,0000.0%21,5000.0%0.16%
+0.6%
Q4 2021$707,000
-28.7%
21,5000.0%0.16%
-33.9%
Q3 2021$992,000
-16.3%
21,5000.0%0.24%
-23.6%
Q2 2021$1,185,000
+6.9%
21,5000.0%0.31%
+6.8%
Q1 2021$1,108,000
+18.9%
21,5000.0%0.29%
+14.9%
Q4 2020$932,000
+23.9%
21,5000.0%0.26%
+4.9%
Q3 2020$752,000
-34.0%
21,5000.0%0.24%
-35.9%
Q2 2020$1,139,000
+49.5%
21,5000.0%0.38%
+9.2%
Q1 2020$762,000
-56.3%
21,500
-41.1%
0.35%
-44.7%
Q4 2019$1,743,000
+47.7%
36,5000.0%0.63%
+15.2%
Q3 2019$1,180,000
-35.2%
36,5000.0%0.54%
-19.3%
Q2 2019$1,821,000
-26.0%
36,5000.0%0.68%
-25.8%
Q1 2019$2,462,000
+86.4%
36,5000.0%0.91%
+11.0%
Q4 2018$1,321,000
-38.8%
36,5000.0%0.82%
-20.1%
Q3 2018$2,159,000
-29.8%
36,5000.0%1.03%
-13.1%
Q2 2018$3,074,000
+3.0%
36,5000.0%1.18%
+1.4%
Q1 2018$2,985,000
+161.2%
36,500
+82.5%
1.16%
+188.8%
Q4 2017$1,143,000
-14.3%
20,0000.0%0.40%
-22.4%
Q3 2017$1,334,000
-29.9%
20,000
-45.9%
0.52%
-28.3%
Q2 2017$1,904,000
+63.0%
37,000
+85.0%
0.72%
+62.0%
Q1 2017$1,168,00020,0000.45%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders